Computational Drug Target Screening through Protein Interaction Profiles

Computational Drug Target Screening through Protein Interaction Profiles

The development of computational methods to discover novel drug-target interactions on a large scale is of great interest. We propose a new method for virtual screening based on protein interaction profile similarity to discover new targets for molecules, including existing drugs. We calculated Targ...

Full description

Bibliographic Details
Main Authors:	Vilar, Santiago, Quezada, Elías, Uriarte, Eugenio, Costanzi, Stefano, Borges, Fernanda, Viña, Dolores, Hripcsak, George
Format:	Online
Language:	English
Published:	Nature Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109486/

Similar Items

Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations
by: Vilar, Santiago, et al.
Published: (2016)

Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
by: Vilar, Santiago, et al.
Published: (2013)

Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling
by: Vilar, Santiago, et al.
Published: (2015)

3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
by: Vilar, Santiago, et al.
Published: (2015)

Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to Pancreatitis
by: Vilar, Santiago, et al.
Published: (2012)

G protein-coupled receptors: computer-aided ligand discovery and computational structural analyses in the 2010s
by: Costanzi, Stefano
Published: (2013)

Systems pharmacology augments drug safety surveillance
by: Lorberbaum, Tal, et al.
Published: (2014)

Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
by: Banda, Juan M., et al.
Published: (2015)

Estimating heritability of drug-induced liver injury from common variants and implications for future study designs
by: Overby, Casey Lynnette, et al.
Published: (2014)

Profile of drug interactions in hospitalized children
by: Martinbiancho, Jacqueline, et al.
Published: (2007)

Exploiting large-scale drug-protein interaction information for computational drug repurposing
by: Liu, Ruifeng, et al.
Published: (2014)

Predicting Drug-Target Interactions Using Drug-Drug Interactions
by: Kim, Shinhyuk, et al.
Published: (2013)

Computational approaches in target identification and drug discovery
by: Katsila, Theodora, et al.
Published: (2016)

Leishmania amastigotes as targets for drug screening
by: Monte-Alegre, Adriano, et al.
Published: (2006)

Next-generation phenotyping of electronic health records
by: Hripcsak, George, et al.
Published: (2013)

Correlating electronic health record concepts with healthcare process events
by: Hripcsak, George, et al.
Published: (2013)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
by: Coelho, Edgar D., et al.
Published: (2016)

3-Phenylcoumarin
by: Matos, Maria J., et al.
Published: (2012)

N-(2-Oxo-2H-chromen-3-yl)cyclohexanecarboxamide
by: Matos, Maria J., et al.
Published: (2012)

3-(4-Methoxybenzoyl)-6-nitrocoumarin
by: Vazquez-Rodriguez, Saleta, et al.
Published: (2013)

Drug interaction in the emergency service
by: Okuno, Meiry Fernanda Pinto, et al.
Published: (2013)

Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile
by: van Laarhoven, Twan, et al.
Published: (2013)

Exploring drug-target interaction networks of illicit drugs
by: Atreya, Ravi V, et al.
Published: (2013)

A 96-well DNase I footprinting screen for drug–DNA interactions
by: Ellis, Tom, et al.
Published: (2007)

Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms
by: Axelrod, Mark, et al.
Published: (2013)

Novel screening techniques for ion channel targeting drugs
by: Obergrussberger, Alison, et al.
Published: (2015)

Identification of drug candidate for osteoporosis by computational bioinformatics analysis of gene expression profile
by: Yu, Guiyong, et al.
Published: (2013)

Antihypertensive Drugs Metabolism: An Update to Pharmacokinetic Profiles and Computational Approaches
by: Zisaki, Aikaterini, et al.
Published: (2015)

lncRNA-screen: an interactive platform for computationally screening long non-coding RNAs in large genomics datasets
by: Yixiao Gong, et al.
Published: (2017-06-01)

Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics
by: Albers, D. J., et al.
Published: (2012)

Evaluation considerations for EHR-based phenotyping algorithms: A case study for drug-induced liver injury
by: Overby, Casey Lynnette, et al.
Published: (2013)

Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks
by: Xu, Jingyu, et al.
Published: (2016)

Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: A structure-based drug designing approach
by: Rajesh Kumar Kesharwani, et al.
Published: (2013-04-01)

Molecular Evolution of the Transmembrane Domains of G Protein-Coupled Receptors
by: Fatakia, Sarosh N., et al.
Published: (2011)

Graph analysis of β2 adrenergic receptor structures: a “social network” of GPCR residues
by: Sheftel, Samuel, et al.
Published: (2013)

Computer applications for prediction of protein–protein interactions and rational drug design
by: Grosdidier, Solène, et al.
Published: (2009)

INDI: a computational framework for inferring drug interactions and their associated recommendations
by: Gottlieb, Assaf, et al.
Published: (2012)

Profiling Physical Activity, Diet, Screen and Sleep Habits in Portuguese Children
by: Pereira, Sara, et al.
Published: (2015)

Discovering the Targets of Drugs Via Computational Systems Biology*
by: Chua, Hon Nian, et al.
Published: (2011)

Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
by: Li, Wei, et al.
Published: (2013)